The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
There will be no significant differences in the efficacy and tolerability between the test
and reference formulations of atorvastatin 20 mg in these Korean adults with primary
hypercholesterolemia.